Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Warts 2Virus Diseases 1Skin Diseases, Viral 1Skin Diseases, Infectious 1Skin Diseases 1Sexually Transmitted Diseases, Viral 1Sexually Transmitted Diseases 1Papillomavirus Infections 1Condylomata Acuminata 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cryotherapy 2Cholecalciferol 2Cantharidin 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1green tea extract polyphenone E 1VP-102 1Sugars 1Photochemotherapy 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Maltose 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Warts × Cantharidin × Clear all
NCT03981822 2024-11-27

CARE-1

Verrica Pharmaceuticals Inc.

Phase 2 Completed
105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT05070754 2024-04-05

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Medical University of South Carolina

Phase 4 Completed
17 enrolled 13 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡